Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15,880 CZK | +0.51% | -1.37% | +1.15% |
Mar. 26 | Philip Morris CR a.s. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Philip Morris CR a.s.(SEP:TABAK) dropped from FTSE All-World Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company returns high margins, thereby supporting business profitability.
- The company is one of the best yield companies with high dividend expectations.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.15% | 1.85B | - | ||
+2.14% | 149B | B- | ||
+1.02% | 19.52B | A- | ||
+5.54% | 5.26B | B- | ||
+57.08% | 2.16B | - | C+ | |
-8.42% | 1.63B | - | D+ | |
-23.87% | 1.26B | - | B+ | |
0.00% | 660M | - | - | |
+5.55% | 491M | C+ | ||
-20.75% | 425M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- TABAK Stock
- Ratings Philip Morris CR